Coldstream Capital Management Inc. Has $4.96 Million Stock Holdings in Danaher Corporation $DHR

Coldstream Capital Management Inc. lifted its holdings in Danaher Corporation (NYSE:DHR) by 39.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 21,671 shares of the conglomerate’s stock after purchasing an additional 6,129 shares during the quarter. Coldstream Capital Management Inc.’s holdings in Danaher were worth $4,961,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of DHR. JPL Wealth Management LLC bought a new position in shares of Danaher during the third quarter worth about $25,000. Elevated Capital Advisors LLC bought a new position in shares of Danaher during the fourth quarter worth about $26,000. WFA of San Diego LLC bought a new position in shares of Danaher during the second quarter worth about $26,000. ANTIPODES PARTNERS Ltd acquired a new position in Danaher during the 3rd quarter worth approximately $27,000. Finally, Financial Life Planners acquired a new position in Danaher during the 3rd quarter worth approximately $32,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have weighed in on the company. Jefferies Financial Group reaffirmed a “buy” rating and set a $245.00 price target on shares of Danaher in a research report on Tuesday, April 21st. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Danaher in a research report on Friday, March 27th. JPMorgan Chase & Co. reduced their price target on Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Wolfe Research reduced their price target on Danaher from $260.00 to $230.00 and set an “outperform” rating for the company in a research report on Wednesday, April 8th. Finally, TD Cowen reduced their price target on Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Nineteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average price target of $238.65.

Danaher Trading Up 0.1%

NYSE:DHR opened at $172.12 on Monday. The company has a market cap of $121.82 billion, a P/E ratio of 33.29, a price-to-earnings-growth ratio of 2.30 and a beta of 0.81. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The business has a 50 day moving average price of $183.52 and a two-hundred day moving average price of $208.70.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating the consensus estimate of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.88 EPS. As a group, analysts expect that Danaher Corporation will post 8.43 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is presently 30.95%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.